Gilgamesh Pharmaceuticals Successfully Completes Phase 1 SAD/MAD Clinical Trials of GM-1020

Small Pharma Reports Positive Top-line Data from SPL026 (DMT)-SSRI Drug Interaction...

Numinus Wellness Inc. Announces At-The-Market Offering Equity Program

Introduction to Psychedelic Therapy and Career Pathways

A Vital Journey: Blue Osa, Costa Rica

PT444 – A Glimpse Into the Psychedelic Neuroscience Landscape

Psychedelics Today Affiliate Webinar: A Course Overview and Q&A Session

The Ultimate Guide to Psychedelics in Australia

Transcend Therapeutics and Yale awarded U.S. Department of Defense grant to...

FILAMENT HEALTH AND JAGUAR HEALTH JOINT VENTURE MAGDALENA BIOSCIENCES COMPLETES IMPORT...

Load more